BMN 111 + Normal Saline
Phase 1Completed 0 watching 0 views this week💤 Quiet
30
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Achondroplasia
Conditions
Achondroplasia
Trial Timeline
Feb 1, 2012 → Jun 1, 2012
NCT ID
NCT01590446About BMN 111 + Normal Saline
BMN 111 + Normal Saline is a phase 1 stage product being developed by BioMarin Pharmaceutical for Achondroplasia. The current trial status is completed. This product is registered under clinical trial identifier NCT01590446. Target conditions include Achondroplasia.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01590446 | Phase 1 | Completed |
Competing Products
20 competing products in Achondroplasia